Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chenghan Mei"'
Autor:
Yao He, Jie Yang, Fengying Hu, Min Liao, Yuru Nie, Xiaoxia Zhu, Tao Zhang, Keer Song, Qinxi Li, Xiaojie Li, Chenghan Mei, Zhe Wu, Qiang Lu, Zhihui Zhong
Publikováno v:
Animal Models and Experimental Medicine, Vol 6, Iss 2, Pp 103-110 (2023)
Abstract Background We aimed to prepare a non‐invasive, reproducible, and controllable rat model of intracerebral hemorrhage with focused ultrasound (FUS). Methods A rat intracerebral hemorrhage (ICH) model was established by combining FUS and micr
Externí odkaz:
https://doaj.org/article/b0a7c3d9598347129ce798e82aa3e54d
Publikováno v:
Frontiers in Environmental Science, Vol 11 (2023)
Introduction: Prothioconazole is a triazolinthione fungicide widely used to control diseases on various crops caused by Ascomycetes, Basidiomycetes, and Imperfecti fungi. However, in view of the rapid transformation of parent prothioconazole to its m
Externí odkaz:
https://doaj.org/article/36bb8085007442268d284baeb804d09d
Publikováno v:
Marine Drugs, Vol 15, Iss 2, p 39 (2017)
Lung cancer is the leading cause of cancer mortality worldwide and non-small-cell lung cancer (NSCLC) is the most common type. Marine plants provide rich resources for anticancer drug discovery. Fucoxanthin (FX), a Laminaria japonica extract, has att
Externí odkaz:
https://doaj.org/article/4534b42b41d54023ad84cb1cbef2ab6f
Autor:
Chuanjiang, Tao, Chenghan, Mei, Liying, Zhang, Shuang, Li, Yizhou, Yan, Dongmei, She, Xuehua, An, Qiang, Fu, Entang, Pu, Lingmei, Tao, Ran, Liu, Hongjun, Zhang, Xiuzhu, Huang
Publikováno v:
In Heliyon 15 April 2024 10(7)
Publikováno v:
Scientific Reports
Gefitinib (Gef) provides clinical benefits to non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. However, acquired resistance (AR) is a major obstacle to effective Gef therapy. This study demonstrated that resveratrol (Res) c